FDA Got Too Close To Drug Firms: GAO

Law360, New York (November 9, 2010, 4:50 PM EST) -- A government audit released Tuesday gives the U.S. Food and Drug Administration high marks for its rapid response to the 2008 contamination of the blood thinner heparin imported from China, but criticizes the agency for accepting volunteer work from people and firms with ties to the heparin industry.

During the height of the heparin crisis, the FDA accepted unpaid help in developing a better test for the contaminant from two scientists who were also paid consultants for two of the primary firms associated with contaminated heparin,...
To view the full article, register now.